12-bromo-3-[4-(diethylamino)piperidin-1-yl]-5,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2,4,6,10,12-hexaene-4-carbonitrile

C20H23BrN6 — CID 58266811

IUPAC12-bromo-3-[4-(diethylamino)piperidin-1-yl]-5,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2,4,6,10,12-hexaene-4-carbonitrile
SMILESCCN(CC)C1CCN(c2c(C#N)ncc3[nH]c4ncc(Br)cc4c23)CC1
InChIInChI=1S/C20H23BrN6/c1-3-26(4-2)14-5-7-27(8-6-14)19-16(10-22)23-12-17-18(19)15-9-13(21)11-24-20(15)25-17/h9,11-12,14H,3-8H2,1-2H3,(H,24,25)
InChIKeyVAVICUCODRHEHI-UHFFFAOYSA-N
MW427.35 g/mol
LogP4.06
Rot. Bonds4

About 12-bromo-3-[4-(diethylamino)piperidin-1-yl]-5,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2,4,6,10,12-hexaene-4-carbonitrile

12-bromo-3-[4-(diethylamino)piperidin-1-yl]-5,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2,4,6,10,12-hexaene-4-carbonitrile (PubChem CID 58266811) has the molecular formula C20H23BrN6 and a molecular weight of 427.35 g/mol. Its IUPAC name is 12-bromo-3-[4-(diethylamino)piperidin-1-yl]-5,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2,4,6,10,12-hexaene-4-carbonitrile.

Molecular Properties

Compound Name12-bromo-3-[4-(diethylamino)piperidin-1-yl]-5,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2,4,6,10,12-hexaene-4-carbonitrile
PubChem CID58266811
Molecular FormulaC20H23BrN6
Molecular Weight427.35 g/mol
Exact Mass426.12
IUPAC Name12-bromo-3-[4-(diethylamino)piperidin-1-yl]-5,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2,4,6,10,12-hexaene-4-carbonitrile
SMILESCCN(CC)C1CCN(c2c(C#N)ncc3[nH]c4ncc(Br)cc4c23)CC1
InChIInChI=1S/C20H23BrN6/c1-3-26(4-2)14-5-7-27(8-6-14)19-16(10-22)23-12-17-18(19)15-9-13(21)11-24-20(15)25-17/h9,11-12,14H,3-8H2,1-2H3,(H,24,25)
InChIKeyVAVICUCODRHEHI-UHFFFAOYSA-N
XLogP4.06
TPSA71.84 Ų
H-Bond Donors1
H-Bond Acceptors5
Rotatable Bonds4
Heavy Atoms27
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500427.35
LogP ≤ 54.06
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 105

Analyze 12-bromo-3-[4-(diethylamino)piperidin-1-yl]-5,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2,4,6,10,12-hexaene-4-carbonitrile with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 12-bromo-3-[4-(diethylamino)piperidin-1-yl]-5,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2,4,6,10,12-hexaene-4-carbonitrile?
The IUPAC name of 12-bromo-3-[4-(diethylamino)piperidin-1-yl]-5,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2,4,6,10,12-hexaene-4-carbonitrile (CID 58266811) is 12-bromo-3-[4-(diethylamino)piperidin-1-yl]-5,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2,4,6,10,12-hexaene-4-carbonitrile.
What is the SMILES notation for 12-bromo-3-[4-(diethylamino)piperidin-1-yl]-5,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2,4,6,10,12-hexaene-4-carbonitrile?
The canonical SMILES for 12-bromo-3-[4-(diethylamino)piperidin-1-yl]-5,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2,4,6,10,12-hexaene-4-carbonitrile is CCN(CC)C1CCN(c2c(C#N)ncc3[nH]c4ncc(Br)cc4c23)CC1.
What is the InChIKey of 12-bromo-3-[4-(diethylamino)piperidin-1-yl]-5,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2,4,6,10,12-hexaene-4-carbonitrile?
The InChIKey is VAVICUCODRHEHI-UHFFFAOYSA-N. The full InChI is InChI=1S/C20H23BrN6/c1-3-26(4-2)14-5-7-27(8-6-14)19-16(10-22)23-12-17-18(19)15-9-13(21)11-24-20(15)25-17/h9,11-12,14H,3-8H2,1-2H3,(H,24,25).
What are the key properties of 12-bromo-3-[4-(diethylamino)piperidin-1-yl]-5,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2,4,6,10,12-hexaene-4-carbonitrile?
12-bromo-3-[4-(diethylamino)piperidin-1-yl]-5,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2,4,6,10,12-hexaene-4-carbonitrile has a molecular weight of 427.35 g/mol, XLogP of 4.06, 4 rotatable bonds, 1 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for 12-bromo-3-[4-(diethylamino)piperidin-1-yl]-5,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2,4,6,10,12-hexaene-4-carbonitrile is sourced from PubChem (CID 58266811), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).